Literature DB >> 18392137

Hypoxia increases breast cancer cell-induced lymphatic endothelial cell migration.

Maria Mikhaylova1, Noriko Mori, Flonné B Wildes, Piotr Walczak, Barjor Gimi, Zaver M Bhujwalla.   

Abstract

Because tumors are characterized by hypoxic environments, we used a novel in vitro noninvasive magnetic resonance imaging assay to examine the influence of invasive MDA-MB-231 breast cancer cells on the invasion and migration of human dermal lymphatic microvascular endothelial cells (HMVEC-dLy) under normoxic and hypoxic conditions. Nonmalignant immortalized MCF-12A human mammary epithelial cells instead of cancer cells or chambers with HMVEC-dLy alone were used as controls for comparison. HMVEC-dLy cells were labeled with a T(2) contrast agent (Feridex), and their invasion and migration through extracellular matrix under normoxic and hypoxic conditions were monitored using magnetic resonance imaging. A significant increase in the invasion and migration of HMVEC-dLy cells was detected in the presence of cancer cells, which further increased significantly under hypoxic conditions. HMVEC-dLy cells formed interconnecting strands extending toward the cancer cells under normoxic but not under hypoxic conditions. Following reoxygenation, these interconnecting strands, extending from HMVEC-dLy cells toward the cancer cells, were observed. These data demonstrate the importance of hypoxia in lymphatic endothelial cell invasion and migration through extracellular matrix in the presence of cancer cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18392137      PMCID: PMC2288542          DOI: 10.1593/neo.07854

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  42 in total

1.  Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents.

Authors:  Joseph A Frank; Holly Zywicke; E K Jordan; Jennifer Mitchell; Bobbi K Lewis; Brad Miller; L Henry Bryant; Jeff W M Bulte
Journal:  Acad Radiol       Date:  2002-08       Impact factor: 3.173

2.  Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.

Authors:  S P Gunningham; M J Currie; C Han; K Turner; P A Scott; B A Robinson; A L Harris; S B Fox
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

Review 3.  Lymphatic function, lymphangiogenesis, and cancer metastasis.

Authors:  M A Swartz; M Skobe
Journal:  Microsc Res Tech       Date:  2001-10-15       Impact factor: 2.769

Review 4.  Expression of hypoxia-inducible factor 1: mechanisms and consequences.

Authors:  G L Semenza
Journal:  Biochem Pharmacol       Date:  2000-01-01       Impact factor: 5.858

5.  Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis.

Authors:  M Skobe; T Hawighorst; D G Jackson; R Prevo; L Janes; P Velasco; L Riccardi; K Alitalo; K Claffey; M Detmar
Journal:  Nat Med       Date:  2001-02       Impact factor: 53.440

6.  Placenta growth factor gene expression is induced by hypoxia in fibroblasts: a central role for metal transcription factor-1.

Authors:  C J Green; P Lichtlen; N T Huynh; M Yanovsky; K R Laderoute; W Schaffner; B J Murphy
Journal:  Cancer Res       Date:  2001-03-15       Impact factor: 12.701

7.  Hypoxia/Notch signaling in primary culture of rat lymphatic endothelial cells.

Authors:  Hideki Ota; Ken-Ichi Katsube; Jyun-Ichi Ogawa; Masaki Yanagishita
Journal:  FEBS Lett       Date:  2007-10-12       Impact factor: 4.124

Review 8.  Lymphangiogenesis and tumor metastasis.

Authors:  Michael S Pepper; Jean-Christophe Tille; Riccardo Nisato; Mihaela Skobe
Journal:  Cell Tissue Res       Date:  2003-07-18       Impact factor: 5.249

Review 9.  The role of tumor lymphangiogenesis in metastatic spread.

Authors:  Steven A Stacker; Megan E Baldwin; Marc G Achen
Journal:  FASEB J       Date:  2002-07       Impact factor: 5.191

Review 10.  Lymphangiogenesis and cancer metastasis.

Authors:  Steven A Stacker; Marc G Achen; Lotta Jussila; Megan E Baldwin; Kari Alitalo
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

View more
  20 in total

Review 1.  MRI and MRS of intact perfused cancer cell metabolism, invasion, and stromal cell interactions.

Authors:  Marie-France Penet; Tariq Shah; Flonne Wildes; Balaji Krishnamachary; Santosh K Bharti; Jesus Pacheco-Torres; Dmitri Artemov; Zaver M Bhujwalla
Journal:  NMR Biomed       Date:  2019-01-28       Impact factor: 4.044

2.  Molecular and functional imaging of invasion and metastasis: windows into the metastatic cascade.

Authors:  Ioannis Stasinopoulos; Marie-France Penet; Balaji Krishnamachary; Zaver M Bhujwalla
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

3.  Phosphorescent nanoparticles for quantitative measurements of oxygen profiles in vitro and in vivo.

Authors:  Nak Won Choi; Scott S Verbridge; Rebecca M Williams; Jin Chen; Ju-Young Kim; Russel Schmehl; Cornelia E Farnum; Warren R Zipfel; Claudia Fischbach; Abraham D Stroock
Journal:  Biomaterials       Date:  2012-01-10       Impact factor: 12.479

4.  Metastasis-associated protein 1 induces VEGF-C and facilitates lymphangiogenesis in colorectal cancer.

Authors:  Bin Du; Zhen-Yu Yang; Xue-Yun Zhong; Mao Fang; Yong-Rong Yan; Guo-Long Qi; Yun-Long Pan; Xu-Long Zhou
Journal:  World J Gastroenterol       Date:  2011-03-07       Impact factor: 5.742

5.  A novel microfluidic platform for high-resolution imaging of a three-dimensional cell culture under a controlled hypoxic environment.

Authors:  Kenichi Funamoto; Ioannis K Zervantonakis; Yuchun Liu; Christopher J Ochs; Choong Kim; Roger D Kamm
Journal:  Lab Chip       Date:  2012-11-21       Impact factor: 6.799

6.  Regulation of membrane-type 4 matrix metalloproteinase by SLUG contributes to hypoxia-mediated metastasis.

Authors:  Chi-Hung Huang; Wen-Hao Yang; Shyue-Yih Chang; Shyh-Kuan Tai; Cheng-Hwei Tzeng; Jung-Yie Kao; Kou-Juey Wu; Muh-Hwa Yang
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

7.  The War on Cancer rages on.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

8.  Hypoxia-specific drug tirapazamine does not abrogate hypoxic tumor cells in combination therapy with irinotecan and methylselenocysteine in well-differentiated human head and neck squamous cell carcinoma a253 xenografts.

Authors:  Arup Bhattacharya; Károly Tóth; Farukh A Durrani; Shousong Cao; Harry K Slocum; Sreenivasulu Chintala; Youcef M Rustum
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715

9.  Regulation of G(1) arrest and apoptosis in hypoxia by PERK and GCN2-mediated eIF2alpha phosphorylation.

Authors:  Yan Liu; Csaba László; Yi Liu; Wei Liu; Xiaozhuo Chen; Susan C Evans; Shiyong Wu
Journal:  Neoplasia       Date:  2010-01       Impact factor: 5.715

10.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.